A cohort study conducted in Sweden between spanning the year of 2017 has investigated the risk of serious infection associated with disease-modifying therapies for multiple sclerosis (MS), compared to injectable therapies interferon beta and glatiramer acetate (GA)....
On the basis of potent anti-inflammatory effects, a recent randomized, double-blind trial involving of treatment with low dose colchicine (0.5 mg daily) after myocardial infarction has been completed, randomising 2366 subjects to the active drug and 2379 to receive...
Researchers from the prestigious Mayo Clinic have recently turned attention to two issues that seem ubiquitous in modern health care: electronic health record (EHR) usability, and professional burnout among physicians. Using a cross-sectional survey of US physicians...
American researchers have recently assessed an enhanced recovery after surgery (ERAS) program employed in patients undertaking elective caesarean delivery. The study included 4,689 women from a period 12 months before the program was started, and 4,624 women from the...
Researchers have recently sought to estimate the risk of hip fracture risk associated with concurrent exposure to multiple drugs known to increase the risk of this outcome, examining hip fracture risk associated with treatment with a combination of 1, 2, or 3 or more...
